NASDAQ:VALN

Valneva (VALN) Stock Price, News & Analysis

Valneva logo
$5.16 -0.20 (-3.73%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$5.08 -0.08 (-1.55%)
As of 11/20/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Valneva Stock (NASDAQ:VALN)

Advanced

Key Stats

Today's Range
$5.11
▼
$5.30
50-Day Range
$5.16
▼
$6.67
52-Week Range
$4.75
▼
$12.18
Volume
17,554 shs
Average Volume
10,763 shs
Market Capitalization
$491.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.30
Consensus Rating
Reduce

Company Overview

Valneva is a specialty vaccine company focused on developing, manufacturing and commercializing vaccines for infectious diseases. Founded in 2013 through the combination of Vivalis and Intercell, the company is headquartered in Saint-Herblain, France, and serves markets in Europe, North America and other regions through direct operations and commercial partners.

Its marketed vaccines include IXIARO, for prevention of Japanese encephalitis, and DUKORAL, an oral vaccine for cholera. Valneva also developed IXCHIQ, a vaccine to prevent disease caused by chikungunya virus, which has received regulatory authorization in the United States and Europe.

The company continues to develop vaccines for diseases with limited prevention options. Its pipeline has included VLA15, a Lyme disease vaccine candidate being developed with Pfizer, alongside other research and development programs.

AI Generated. May Contain Errors.

Valneva Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

VALN MarketRank™: 
2.204210526315 of 5 stars

Valneva scored higher than 44% of companies evaluated by MarketBeat, and ranked 562nd out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Valneva has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 2 sell ratings.

  • Upside Potential

    Valneva has a consensus price target of $9.30, representing about 80.2% upside from its current price of $5.16.

  • Amount of Analyst Coverage

    Valneva has only been the subject of 1 research reports in the past 90 days.

  • Read more about Valneva's stock forecast and price target.
  • Earnings Growth

    Earnings for Valneva are expected to grow in the coming year, from ($1.27) to $0.44 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Valneva is -2.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Valneva is -2.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Valneva has a P/B Ratio of 3.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Valneva's valuation and earnings.
  • Percentage of Shares Shorted

    0.06% of the float of Valneva has been sold short.
  • Short Interest Ratio / Days to Cover

    Valneva has a short interest ratio ("days to cover") of 2.05, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Valneva has recently decreased by 75.00%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Valneva does not currently pay a dividend.

  • Dividend Growth

    Valneva does not have a long track record of dividend growth.

  • News Sentiment

    Valneva has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Valneva this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Valneva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.91% of the stock of Valneva is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    11.39% of the stock of Valneva is held by institutions.

  • Read more about Valneva's insider trading history.
Receive VALN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Valneva and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VALN Stock News Headlines

Valneva (VALN) Set to Release Earnings on Tuesday
Stifel sees 191% upside potential for Valneva
CFA: Bank of America Said THIS
On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.tc pixel
Did Valneva's Fall Catch You Out? What Bears Saw
See More Headlines

VALN Stock Analysis - Frequently Asked Questions

Valneva's stock was trading at $8.82 at the beginning of 2026. Since then, VALN shares have decreased by 41.5% and is now trading at $5.16.

Valneva SE Sponsored ADR (NASDAQ:VALN) issued its quarterly earnings data on Friday, August, 14th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.21. The company earned $39.37 million during the quarter, compared to the consensus estimate of $44.17 million. Valneva had a negative trailing twelve-month return on equity of 153.20% and a negative net margin of 110.33%.
Read the conference call transcript
.

Valneva (VALN) raised $93 million in an initial public offering on Thursday, May 6th 2021. The company issued 3,500,000 shares at $24.04-$28.85 per share. Goldman Sachs, Jefferies, Guggenheim Securities and Bryan, Garnier & Co. acted as the underwriters for the IPO.

Valneva's top institutional shareholders include Lionhunter Capital Management LLC (0.05%).

Shares of VALN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Valneva investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), BioNTech (BNTX), Tesla (TSLA), Palantir Technologies (PLTR), PayPal (PYPL) and Qualcomm (QCOM).

Company Calendar

Last Earnings
8/14/2026
Today
11/22/2026
Next Earnings (Estimated)
11/24/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:VALN
CIK
1836564
Fax
N/A
Employees
674
Year Founded
2013

Price Target and Rating

High Price Target
$12.00
Low Price Target
$4.90
Potential Upside/Downside
+80.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
11.73
P/E Growth
N/A
Net Income
-$130.33 million
Net Margins
-110.33%
Pretax Margin
N/A
Return on Equity
-153.20%
Return on Assets
-39.50%

Debt

Debt-to-Equity Ratio
2.04
Current Ratio
2.16
Quick Ratio
1.69

Sales & Book Value

Annual Sales
$142.94 million
Price / Sales
3.44
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.39 per share
Price / Book
3.71

Miscellaneous

Outstanding Shares
95,190,000
Free Float
80,997,000
Market Cap
$491.18 million
Optionable
Not Optionable
Beta
1.37

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:VALN) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners